I am a surgical oncologist at Memorial Sloan Kettering who specializes specifically in caring for people with soft tissue sarcoma. Sarcoma is a rare cancer with more than 80 subtypes, each with its own treatment strategy. I understand the challenges each subtype poses. I use my expertise to provide my patients with an individualized recommendation about the best treatment for them.
Along with members of the pathology, radiation oncology, and medical oncology departments, I design treatment plans that optimize my patients’ chance for a cure. As much as possible, each patient should be able to return to normal after surgery. I almost always perform limb-sparing procedures for tumors on the legs and arms. When it is safe to do so, I use laparoscopic and minimally invasive techniques for tumors in and around the abdomen.
After surgery, I follow my patients long-term to help them deal with any side effects. I closely monitor patients who are at an increased risk of developing a second sarcoma, such as those with Gardner’s syndrome or neurofibromatosis. If we detect those tumors early, we can reduce the long-term complications.
In addition to seeing patients, I conduct an active research program. I look at the genetic errors that lead to the development of soft tissue tumors, such as liposarcomas, solitary fibrous tumors, and desmoid-type fibromatosis. These changes can be used to identify new drugs to treat the tumors. The research can also help us predict which patients may benefit most from specific treatments. My work has been funded by a range of organizations, including the American Cancer Society, the Food and Drug Administration, the American Society of Clinical Oncology, the American College of Surgeons, and the Kristen Ann Carr Foundation.
I am actively involved in teaching other doctors about caring for people with sarcoma. I also write articles, book chapters, and reviews on the management and biology of soft tissue sarcomas, and serve on multiple editorial boards. I am on the board of the Melanoma and Sarcoma Disease Site Working Group for the Society of Surgical Oncology and I chair the Scientific Advisory Board of the Desmoid Tumor Research Foundation. My leadership roles and research allow me to continuously improve treatment, not only for my own patients and those of our team but also for soft tissue sarcoma patients around the world.
- Clinical Expertise: Soft Tissue Sarcoma; Gastrointestinal Stromal Tumor; Liposarcoma; Malignant Fibrous Histiocytoma (Undifferentiated Pleomorphic Sarcoma); Leiomyosarcoma; Myxofibrosarcoma; Desmoid Tumor; Solitary Fibrous Tumor; Epithelioid Sarcoma; Synovial Sarcoma; Malignant Peripheral Nerve Sheath Tumor; Angiosarcoma; Fibrosarcoma; Dermatofibrosarcoma Protuberans; Rhabdomyosarcoma; Ewing Sarcoma; Neurofibromatosis; Gardner’s Syndrome
- Languages Spoken: English
- Education: MD, Harvard University
- Residencies: General Surgery - Georgetown University Medical Center
- Fellowships: Surgical Oncology - Memorial Sloan Kettering Cancer Center
- Board Certifications: Surgery
Selected Book Chapters
Crago AM and Singer S. Soft Tissue Sarcoma. ACS: Principles and Practice of Surgery Ontario: Decker; 2011.
Singer, S, Tap, WD, Crago, AM, and O’Sullivan, B. Soft Tissue Sarcoma. VT DeVita, TS Lawrence, SA Rosenberg. Cancer: Principles & Practice of Oncology Wolters Kluwer Health; 2014; 10th.
Crago AM. Soft Tissue Sarcoma – Extremity. in Clinical Decision Support: Surgery, edited by Lillemoe K, de Moya M, House M, Hutter M. 2016. Decision Support in Medicine, LLC. Wilmington, DE.
Crago AM and Singer S. Soft Tissue Sarcoma. Scientific American Surgery Ontario: Decker; 2015.
Gounder, M, Ravi, V, Yamada, Y, Carvajal, R, and Crago, A. Sarcoma of Soft Tissue. American Cancer Society Textbook of Clinical Oncology, in press.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more